Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

First combination monoclonal antibody therapy for chronic HBV shows promise in phase I

Nov. 3, 2000

InKine selects tradenames for CBP-1011

Oct. 31, 2000

Promising new colon-specific 5-ASA prodrug developed by U.S. and Korean scientists

Oct. 31, 2000

Safe new agents from Ajinomoto with potential in irritable bowel syndrome

Oct. 30, 2000

Pharmacokinetics, disposition and metabolism of new hepatic antiinflammatory TA-510

Oct. 30, 2000

Selective M3 receptor antagonists and their use described by Japanese scientists

Oct. 24, 2000

Prilosec receives positive recommendation for OTC status

Oct. 24, 2000

Encouraging data reported for Emitasol in diabetic gastroparesis

Oct. 23, 2000

IND for hepatitis C gene fusion therapy submitted by Human Genome Sciences

Oct. 20, 2000

IBS treatment launched in Japan by Hokuriku and Fujisawa

Oct. 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...